LinkedIn



Metronidazole Tablets, 250mg: Recall – Underweight Tablets

January 2011

Teva Pharmaceuticals and FDA notified healthcare professionals and the public of a recall of Metronidazole Tablets USP, 250mg, lot #312566, expiration date 05/2012. This product lot is being recalled due to the presence of underweight tablets. Underweight tablets may not contain the full amount of active ingredient within a single tablet, and a consumer may not receive the prescribed dose. This may cause the infection the drug was intended to treat to worsen or recur, which could be life-threatening when treating severe infections.

To read the MedWatch safety alert, including a link to the Press Release, please visit the FDA website at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm239312.htm

Please click here to download the 2011 NYC DOHMH Health Update # 1.